Advanced search
Publication Cover
International Journal of Nanomedicine Volume 14, 2019 - Issue
Submit an article Journal homepage
120
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Targeting breast cancer stem cells by a self-assembled, aptamer-conjugated DNA nanotrain with preloading doxorubicin

Zhiyuan Xu1 School of Pharmacy, Nanjing Medical University, Nanjing211166, People’s Republic of China
,
Ronghua Ni1 School of Pharmacy, Nanjing Medical University, Nanjing211166, People’s Republic of China
&
Yun Chen1 School of Pharmacy, Nanjing Medical University, Nanjing211166, People’s Republic of China;2 State Key Laboratory of Reproductive Medicine, Nanjing210029, People’s Republic of ChinaCorrespondence[email protected]
Pages 6831-6842 | Published online: 27 Aug 2019

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Li Lv, Yonghui Shi, Junyan Wu & Guocheng Li. (2021) Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting. International Journal of Nanomedicine 16, pages 1487-1508.
Read now

Articles from other publishers (18)

Mengyuan Cao, Anthony Vial, Laetitia Minder, Aurore Guédin, Sébastien Fribourg, Laurent Azéma, Cécile Feuillie, Michael Molinari, Carmelo Di Primo, Philippe Barthélémy & Leblond Chain Jeanne. (2023) Aptamer-based nanotrains and nanoflowers as quinine delivery systems. International Journal of Pharmaceutics: X 5, pages 100172.
Crossref
Yali Liu, Wuyi Liu, Guobing Li, Wenjing Lai, Changpeng Hu, Qian Zhang, Min Zhou, Laichun Lu & Jingbin Huang. (2023) Cu 2−x Se nanoparticles suppress cell proliferation and migration in hepatocellular carcinoma by impairing mitochondrial respiration . Biomedical Materials 18:3, pages 035013.
Crossref
Biao Liu, Jinrong Wang, Yongbo Peng, Hongliang Zeng, Qun Zhang, Minhua Deng, Wei Xiang, Jiahao Liu, Xing Hu, Xuewen Liu, Jianfei Xie, Weibin Hou, Jin Tang, Zhi Long, Long Wang & Jianye Liu. (2023) CD71/CD44 dual-aptamer-gemcitabine conjugate for tumor co-targeting treatment of bladder cancer. Chemical Engineering Journal 464, pages 142597.
Crossref
Biao Liu, Jiahao Liu, Xing Hu, Wei Xiang, Weibin Hou, Chao Li, Jinrong Wang, Kun Yao, Jin Tang, Zhi Long, Long Wang & Jianye Liu. (2023) Recent advances in aptamer-based therapeutic strategies for targeting cancer stem cells. Materials Today Bio 19, pages 100605.
Crossref
Mengyuan Cao, Anthony Vial, Laetitia Minder, Aurore Guédin, Sébastien Fribourg, Laurent Azéma, Cécile Feuillie, Michael Molinari, Carmelo Di Primo, Philippe Barthélémy & Jeanne Leblond Chain. (2023) WITHDRAWN: Aptamer-based nanotrains and nanoflowers as quinine delivery systems. International Journal of Pharmaceutics 632, pages 122552.
Crossref
Rakshita Grover, Sahil Drall, Neelam Poonia, Gaurav Kumar Jain, Geeta Aggarwal, Viney Lather, Prashant Kesharwani, Deepti Pandita & Ramesh K. Goyal. (2023) CD44 and CD133 aptamer directed nanocarriers for cancer stem cells targeting. European Polymer Journal 183, pages 111770.
Crossref
Liqi Shi, Kun Hu, Xiangjun Li, Jun Zhao & Min Jia. (2022) Doxorubicin and SN-38 inhibit the proliferation of osteosarcoma cells by inducing cell cycle arrest. Process Biochemistry 121, pages 56-68.
Crossref
Hanane Aliouat, Ying Peng, Zoya Waseem, Shengfeng Wang & Wenhu Zhou. (2022) Pure DNA scaffolded drug delivery systems for cancer therapy. Biomaterials 285, pages 121532.
Crossref
Yao Jiang, Huimin Zhou, Wenjing Zhao & Shusheng Zhang. (2022) ATP-Triggered Drug Release of Self-Assembled 3D DNA Nanostructures for Fluorescence Imaging and Tumor Therapy. Analytical Chemistry 94:18, pages 6771-6780.
Crossref
He Ma, Xiaoming Zhang, Long Pang, Bing Yu, Hailin Cong & Youqing Shen. (2022) Mn-dox metal-organic nanoparticles for cancer therapy and magnetic resonance imaging. Dyes and Pigments 199, pages 110080.
Crossref
Jagadish Natesh, Chetan Chandola, Syed Musthapa Meeran & Muniasamy Neerathilingam. (2021) Targeted delivery of doxorubicin through CD44 aptamer to cancer cells. Therapeutic Delivery 12:10, pages 693-703.
Crossref
Luyao Shen, Pengfei Wang & Yonggang Ke. (2021) DNA Nanotechnology‐Based Biosensors and Therapeutics. Advanced Healthcare Materials 10:15, pages 2002205.
Crossref
Yali Liu, Changpeng Hu, Min Zhou, Qian Zhang, Qin Tang, Wenjing Lai & Jingbin Huang. (2021) AMD3100-tagged nano-gold as a targeting nanocarrier for delivery of doxorubicin into lung cancer cells. Materials Express 11:5, pages 618-626.
Crossref
Frank H. T. Nelissen, Wenny J. M. Peeters, Timo P. Roelofs, Anika Nagelkerke, Paul N. Span & Hans A. Heus. (2021) Improving Breast Cancer Treatment Specificity Using Aptamers Obtained by 3D Cell-SELEX. Pharmaceuticals 14:4, pages 349.
Crossref
Zhenbao Liu & Yanfei Liu. 2021. Aptamers for Medical Applications. Aptamers for Medical Applications 77 113 .
Qiuyang Sun, Yu Han, Yuming Yang, Jesús M. de la Fuente, Daxiang Cui & Xiaoqiang Wang. (2020) Application of DNA nanostructures in cancer therapy. Applied Materials Today 21, pages 100861.
Crossref
Zhaoying Fu & Jim Xiang. (2020) Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy. International Journal of Molecular Sciences 21:23, pages 9123.
Crossref
Ronghua Ni, Jianhua Zhu, Zhiyuan Xu & Yun Chen. (2020) A self-assembled pH/enzyme dual-responsive prodrug with PEG deshielding for multidrug-resistant tumor therapy. Journal of Materials Chemistry B 8:6, pages 1290-1301.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.